The Future of Clinical Trials

The time has come to "raise the bar" in cancer clinical trials.

Nivolumab Promising for Advanced Melanoma

Results of a phase 1 trial may raise expectations for better outcomes with lower toxicity.

Idelalisib, Rituximab Combo Effective for Relapsed CLL

Rituximab combined with idelalisib may offer a tolerable alternative therapy for patients with chronic lymphocytic leukemia.

Enter Our April Contest and Win A Nike Fuel Band!

Become an Oncology Practice Pro by participating in this month's contest. Three lucky participants will win a Nike Fuel Band!

Effect of Bariatric Surgery on Endometrial Cancer Risk

Reversing obesity may also reduce a woman's chance of developing uterine cancer.

Palbociclib for Hormone Receptor-positive Breast Cancer

A phase 2 study finds that an inhibitor of CDK-4 and CDK-6 reduced the risk of disease progression by 51%.

Featured Videos


Latest News

FDA Grants Fast Track Designation for Custirsen for mCRPC

The FDA granted Fast Track designation to custirsen when given in combination with cabazitaxel/prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with a docetaxel-containing regimen.

Alvocidib Receives Orphan Drug Designation for AML

The FDA has granted Orphan Drug designation to alvocidib for the treatment of patients with acute myeloid leukemia.

Combined Tobacco, Alcohol Use Spikes Esophageal Cancer Risk

Rates of esophageal squamous cell carcinoma (ESCC) nearly double for those who use tobacco and consume alcohol, compared to individuals who only smoke or drink.

Viewpoints & Cases

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.

Bariatric Surgery May Help Prevent Endometrial Cancer

Bariatric Surgery May Help Prevent Endometrial Cancer

Reversing obesity may also reduce a woman's chance of developing uterine cancer.

A 58-year-old with Stage IV Pancreatic Adenocarcinoma

A 58-year-old with Stage IV Pancreatic Adenocarcinoma

Chief Complaint

R.M. is a 58-year-old male recently diagnosed with stage IV pancreatic adenocarcinoma (Slide 1). He is a mechanical engineer ...

A 55-year-old Woman with Breast Cancer and Shortness of Breath

A 55-year-old Woman with Breast Cancer and Shortness of Breath

Chief Complaint

J.W. is a 55-year-old woman recently admitted to the hospital for worsening shortness of breath (Slide 1).

Relevant Medical History

• ...

From the Board

Expert Perspectives on Breast Cancer Awareness Month

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.

Editorial Advisory Board

 

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Edith A. Perez, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Martin Tallman, MD

Click here for complete profiles

Poll Question


News from Oncology Nurse Advisor

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs